logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
O

Opeyemi A. Jegede

New York University
H指数:17
被引数:2,206

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma

伊匹木单抗、纳武利尤单抗和 Brentuximab Vedotin 治疗复发霍奇金淋巴瘤的随机二期研究

Blood
IF23.1
2026-04-011
PRE
Diefenbach, Catherine S.; Jegede, Opeyemi; Wang, Victoria; Ansell, Stephen M.; Kostakoglu, Lale; Steidl, Christian; Natkunam, Yasodha; Scott, David W.; Ambinder, Richard F.; David, Kevin A.; Advani, Ranjana H.; Bartlett, Nancy L.; Roberston, Michael A.; Thomas, Sachdev P.; Cohen, Jonathon; Ibrahimi, Sami; Goyal, Gaurav; Mehta-Shah, Neha; Amengual, Jennifer E.; Forlenza, Christopher J.; Cole, Peter D.; Duan, Fenghai; Kelly, Kara; Kahl, Brad S.
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma
JOURNAL OF IMMUNOLOGY
IF3.4
2025-11-010
PRE
Wirth, Lena Vanessa; Hugaboom, Miya B.; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueiri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David F.; Plimack, Elizabeth R.; Sosman, Jeffrey; Haas, Naomi; Hurwitz, Michael E.; Hammers, Hans; Stein, Mark; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine J.; Braun, David
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma

三级淋巴结构的存在和耗竭性组织驻留T细胞决定了肾细胞癌对PD-1阻断的临床反应

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Wirth, Lena; Hugaboom, Miya; Street, Kelly; Ruthen, Neil; Jegede, Opeyemi; Schindler, Nicholas; Shah, Valisha; Zaemes, Jacob; El Ahmar, Nourhan; Matar, Sayed; Savla, Varunika; Choueri, Toni; Denize, Thomas; West, Destiny; Mcdermott, David; Plimack, Elizabeth; Sosman, Jeffrey A.; Haas, Naomi B.; Hurwitz, Michael; Hammers, Hans J.; Stein, Mark N.; Alter, Robert; Bilen, Mehmet; Signoretti, Sabina; Atkins, Michael B.; Wu, Catherine; Braun, David
Phase II study of venetoclax added to bendamustine and obinutuzumab in patients with high-risk follicular lymphoma as front-line therapy: PrE0403

II期研究：将venetoclax加入bendamustine和obinutuzumab用于高风险滤泡性淋巴瘤患者的一线治疗：PrE0403

BLOOD CANCER JOURNAL
IF11.6
2025-05-120
OA
Portell, Craig A.; Jegede, Opeyemi A.; Wagner-Johnston, Nina; Nowakowski, Grzegorz S.; Fletcher, Christopher; Cohen, Jonathon B.; Evens, Andrew M.; Rosenstein, Lori J.; Craig, Jeffrey W.; Reddy, Nishitha; Kahl, Brad S.
Tertiary Lymphoid Structures Predict Response to First-Line Nivolumab Therapy in Advanced Renal Cell Carcinoma: Findings from the HCRN GU16-260 Clinical Trial

三级淋巴结构预测晚期肾细胞癌一线Nivolumab治疗的反应: HCRN GU16-260临床试验的结果

LABORATORY INVESTIGATION
IF4.2
2025-03-010
PRE
El Ahmar, Nourhan; Simsek, Berkay; Jegede, Opeyemi; Matar, Sayed; Savla, Varunika; Laimon, Yasmin; Mohanna, Razan; De Oliveira, Gabriel Roberti; Sheshdeh, Aseman Baghari; Delcea, Andrew; Paul, Morgan; Choueiri, Toni; Xie, Wanling; Freeman, Gordon; Braun, David; Haas, Naomi Balzer; Hammers, Hans; Bilen, Mehmet; Stein, Mark; Sosman, Jeffrey; Wu, Catherine; Mcdermott, David; Atkins, Michael; Signoretti, Sabina
Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181

在≤70岁套细胞淋巴瘤患者强化一线化疗免疫治疗中添加或替代Acalabrutinib：ECOG-ACRIN EA4181三臂随机Ⅱ期协作组试验的结果

BLOOD
IF23.1
2024-11-051
PRE
Wagner-Johnston, Nina; Jegede, Opeyemi; Spurgeon, Stephen E.; Maddocks, Kami J.; Yang, David T.; Romanoff, Justin; Paludo, Jonas; Caimi, Paolo F.; Bartlett, Nancy L.; Reagan, Patrick M.; Sawalha, Yazeed; Hoffmann, Marc; Hu, Boyu; Aziz, Ashraf R.; Marques, Helga; Shields, Lale Kosakoglu; Leonard, John P.; Friedberg, Jonathan W.; Kahl, Brad S.
Representation of Minorities in Therapeutic Clinical Trials- a 15-Year Review of Lymphoma Cooperative Group Studies (Alliance A152123)

少数民族在治疗性临床试验中的代表性——淋巴瘤协作组研究15年回顾 (Alliance A152123)

BLOOD
IF23.1
2024-11-050
PRE
Alencar, Alvaro J.; Geyer, Susan M.; Paskett, Electra; Pederson, Levi D.; Dockter, Travis; Ghosh, Nilanjan; Adekola, Kehinde; Unger, Joseph M.; Jegede, Opeyemi; Friedberg, Jonathan W.; Kahl, Brad S.; Dinner, Shira N.; Bartlett, Nancy L.; Blum, Kristie A.; Leonard, John P.
Identification of genetic subtypes in follicular lymphoma
BLOOD CANCER JOURNAL
IF11.6
2024-08-071
OAAI
Shelton, Victoria; Detroja, Rajesh; Liu, Ting; Isaev, Keren; Silva, Anjali; Passerini, Verena; Bakhtiari, Mehran; Calvente, Lourdes; Hong, Michael; He, Michael Y.; Modi, Saloni; Hershenfeld, Samantha A.; Ludvigsen, Maja; Madsen, Charlotte; Hamilton-Dutoit, Stephen; d'Amore, Francesco Annibale; Brodtkorb, Marianne; Johnson, Nathalie A.; Baetz, Tara; LeBrun, David; Tobin, Josh W. D.; Gandhi, Maher K.; Mungall, Andrew J.; Xu, Wei; Ben-Neriah, Susana; Steidl, Christian; Delabie, Jan; Tremblay-LeMay, Rosemarie; Jegede, Opeyemi; Weigert, Oliver; Kahl, Brad; Evens, Andrew M.; Kridel, Robert
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11
CLINICAL CANCER RESEARCH
IF10.2
2024-04-192
PRE
Stearns, Vered; Jegede, Opeyemi A.; Chang, Victor T-S; Skaar, Todd C.; Berenberg, Jeffrey L.; Nand, Ranveer; Shafqat, Atif; Jacobs, Nisha L.; Luginbuhl, William; Gilman, Paul; Benson, Al B., III; Goodman, Judie R.; Buchschacher Jr, Gary L.; Henry, N. Lynn; Loprinzi, Charles L.; Flynn, Patrick J.; Mitchell, Edith P.; Fisch, Michael J.; Sparano, Joseph A.; Wagner, Lynne I.
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)

nivolumab和savage nivolumab/ipilimumab治疗晚期透明细胞肾细胞癌的II期研究的无治疗生存结果 (HCRN GU16-260-Cohort A)

JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2024-04-112
OAAI
Atkins, Michael B.; Jegede, Opeyemi A.; Haas, Naomi B.; Mcdermott, David F.; Bilen, Mehmet A.; Stein, Mark; Sosman, Jeffrey; Alter, Robert; Plimack, Elizabeth R.; Ornstein, Moshe C.; Hurwitz, Michael; Peace, David J.; Einstein, David; Catalano, Paul J.; Hammers, Hans; Regan, Meredith M.
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients
CLINICAL CANCER RESEARCH
IF10.2
2023-12-074
OA
Denize, Thomas; Jegede, Opeyemi A.; Matar, Sayed; El Ahmar, Nourhan; West, Destiny J.; Walton, Emily; Bagheri, Aseman Sheshdeh; Savla, Varunika; Laimon, Yasmin Nabil; Gupta, Saurabh; Vemula, Sai Vikram; Braun, David A.; Burke, Kelly P.; Catalano, Paul J.; Freeman, Gordon J.; Motzer, Robert J.; Atkins, Michael B.; McDermott, David F.; Sharpe, Arlene H.; Choueiri, Toni K.; Signoretti, Sabina
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma
EUROPEAN UROLOGY
IF25.2
2021-07-0140
OAAI
Correa, Andres F.; Jegede, Opeyemi A.; Haas, Naomi B.; Flaherty, Keith T.; Pins, Michael R.; Adeniran, Adebowale; Messing, Edward M.; Manola, Judith; Wood, Christopher G.; Kane, Christopher J.; Jewett, Michael A. S.; Dutcher, Janice P.; DiPaola, Robert S.; Carducci, Michael A.; Uzzo, Robert G.
Expression of T-Cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma
CLINICAL CANCER RESEARCH
IF10.2
2021-03-0150
OAAI
Ficial, Miriam; Jegede, Opeyemi A.; Sant'Angelo, Miriam; Hou, Yue; Flaifel, Abdallah; Pignon, Jean-Christophe; Braun, David A.; Wind-Rotolo, Megan; Sticco-Ivins, Maura A.; Catalano, Paul J.; Freeman, Gordon J.; Sharpe, Arlene H.; Hodi, F. Stephen; Motzer, Robert J.; Wu, Catherine J.; Atkins, Michael B.; McDermott, David F.; Shukla, Sachet A.; Choueiri, Toni K.; Signoretti, Sabina
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

体细胞改变和免疫浸润的相互作用调节晚期透明细胞肾细胞癌对PD-1阻断的反应

NATURE MEDICINE
IF50
2020-05-29572
OAAI
Braun, David A.; Hou, Yue; Bakouny, Ziad; Ficial, Miriam; Sant' Angelo, Miriam; Forman, Juliet; Ross-Macdonald, Petra; Berger, Ashton C.; Jegede, Opeyemi A.; Elagina, Liudmilla; Steinharter, John; Sun, Maxine; Wind-Rotolo, Megan; Pignon, Jean-Christophe; Cherniack, Andrew D.; Lichtenstein, Lee; Neuberg, Donna; Catalano, Paul; Freeman, Gordon J.; Sharpe, Arlene H.; McDermott, David F.; Van Allen, Eliezer M.; Signoretti, Sabina; Wu, Catherine J.; Shukla, Sachet A.; Choueiri, Toni K.

研究方向

暂未获取到该数据
N
Naomi B. Haas
H 指数:54论文数:539被引数:1.4万
T
Toni K. Choueiri
H 指数:149论文数:2,479被引数:12.7万
M
Michael B. Atkins
H 指数:121论文数:1,038被引数:9.4万
D
David F. McDermott
H 指数:109论文数:1,058被引数:8.9万
S
Sabina Signoretti
H 指数:130论文数:1,163被引数:9.6万
C
Catherine J. Wu
H 指数:97论文数:1,284被引数:6.2万
H
Hans J. Hammers
H 指数:61论文数:403被引数:2.6万
J
Jeffrey A. Sosman
H 指数:122论文数:904被引数:12.8万
E
Elizabeth R. Plimack
H 指数:79论文数:766被引数:4.8万
B
Brad S. Kahl
H 指数:74论文数:911被引数:2.7万